Be part of the knowledge.™

In the Pink? Examining Breast Cancer Awareness Campaigns

Media Formats

ReachMD Healthcare Image

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details

Presenters

Overview
Pink ribbon campaigns have been highly successful in rallying recognition and funding around breast cancer. But our guest thinks the cheerful image of such campaigns whitewashes realities of the disease, both in terms of statistics and patient experiences. Plus: Warnings about the drug cocktail known as “bath salts,” and a novel innovation for biomarking GI ailments with color.

Gayle Sulik, PhD

Gayle Sulik, PhD

Matt Birnholz, MD

Matt Birnholz, MD

Michael Greenberg, MD

Michael Greenberg, MD

Recommended

Details

Presenters

Overview
Pink ribbon campaigns have been highly successful in rallying recognition and funding around breast cancer. But our guest thinks the cheerful image of such campaigns whitewashes realities of the disease, both in terms of statistics and patient experiences. Plus: Warnings about the drug cocktail known as “bath salts,” and a novel innovation for biomarking GI ailments with color.

Gayle Sulik, PhD

Gayle Sulik, PhD

Matt Birnholz, MD

Matt Birnholz, MD

Michael Greenberg, MD

Michael Greenberg, MD

Program Chapters

Segment Chapters

Playlist:

Recommended

Phase 3 study results of plozasiran in patients with FCS

Biomarkers of the Storm: Decoding IRI’s Signature

Level Up Your Skills: Tailoring Management of HF

Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy

Navigating Myasthenia Gravis in Adolescents and Young Adults

Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids

Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial

Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial